| Literature DB >> 35408733 |
Mengyuan Wang1,2, Changliang Yao1, Jiayuan Li1, Xuemei Wei1,2, Meng Xu1, Yong Huang1, Quanxi Mei3, De-An Guo1,2.
Abstract
The complexity of metabolites in traditional Chinese medicine (TCM) hinders the comprehensive profiling and accurate identification of metabolites. In this study, an approach that integrates enhanced column separation, mass spectrometry post-processing and result verification was proposed and applied in the identification of flavonoids in Dalbergia odorifera. Firstly, column chromatography fractionation, followed by liquid chromatography-tandem mass spectrometry was used for systematic separation and detection. Secondly, a three-level data post-processing method was applied to the identification of flavonoids. Finally, fragmentation rules were used to verify the flavonoid compounds. As a result, a total of 197 flavonoids were characterized in D. odorifera, among which seven compounds were unambiguously identified in level 1, 80 compounds were tentatively identified by MS-DIAL and Compound Discoverer in level 2a, 95 compounds were annotated by Compound discoverer and Peogenesis QI in level 2b, and 15 compounds were exclusively annotated by using SIRIUS software in level 3. This study provides an approach for the rapid and efficient identification of the majority of components in herbal medicines.Entities:
Keywords: Dalbergia odorifera; flavonoid; mass spectrometry; software
Mesh:
Substances:
Year: 2022 PMID: 35408733 PMCID: PMC9000885 DOI: 10.3390/molecules27072333
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1A flowchart for software-assisted multi-tiered mass spectrometry identification of flavonoids in Dalbergia odorifera.
Figure 2Structures of 39 reference standards and quasi reference standards. (a) reference standards; (b) quasi reference standards from level 2a; (c) quasi reference standards from mzCloud database).
Figure 3Proposed MS fragmentation pathways of Biochanin B; and matching diagram of compound 104 and 68 in MS-DIAL. (a) matching diagram of compound 104 in MS-DIAL; (b) matching diagram of compound 68 in MS-DIAL; (c) proposed MS fragmentation pathways of Biochanin B.
Figure 4Fragment spectra of compounds annotated in Level 2b: (a) compounds annotated by Progenesis QI and (b,c) compounds annotated by Compound Discoverer.
Figure 5Proposed MS fragmentation pathways of compounds F30–F34. (a) F30–F33; (b) F34.
Figure 6Proposed fragmentation pathways and fragments annotation of F35–F39. (a) F35; (b) F36; (c) F37 and F38; (d) F39.